NSABP FC-10: Phase IB Study of Pembrolizumab in Combination with Premetrexed + Oaliplatin in Patients (pts) with Chemo-Refractory Metastatic Colorectal Cancer (Mcrc).
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要